相关实验视频
Updated: Jul 5, 2025

12:08
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
9.3K
以免疫细胞死亡诱导治疗为先决条件,用于随后的免疫治疗
Hui Pan1, Peng Liu2, Guido Kroemer3
1Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France.
International review of cell and molecular biology
|January 15, 2024
概括
使用免疫检查点抑制剂 (ICI) 的抗癌免疫疗法正在扩大. 将诱导免疫细胞死亡 (ICD) 的化疗与ICI结合起来,有望改善癌症治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫检查点抑制剂 (ICI),包括向CTLA-4和PD-1/PD-L1的单克隆抗体,已经彻底改变了癌症治疗,特别是黑色素瘤和各种癌症.
- 在大量患者中,ICI疗法已经显示出持久的回归,导致其被批准作为先进黑色素瘤和其他癌症的第一线治疗.
- 令人惊的是,化疗剂可以通过诱导免疫细胞死亡 (ICD) 来增强抗癌免疫反应,这是一个死亡癌细胞提醒免疫系统对瘤相关抗原的过程.
研究的目的:
- 为了提供一个全面的概述当前的策略,结合免疫细胞死亡 (ICD) 诱导剂与免疫检查点抑制剂 (ICI) 在抗癌疗法.
- 探索结合方法的治疗潜力,利用ICD来提高ICI治疗的疗效.
- 总结研究和临床试验,调查ICD诱导化学疗法和ICI之间的协同作用.
主要方法:
- 审查临床前研究和临床试验,探索ICD诱导剂和ICI的组合.
- 分析目前在抗癌治疗中实施组合方法的策略.
- 综合现有关于ICD和ICI协同作用机制的文献.
主要成果:
- 结合ICD诱导剂和ICI是一种快速发展的研究领域.
- 临床前和临床证据表明,结合这些方法可以带来最佳的治疗效果.
- 目前正在探索各种策略,以有效地将ICD诱导与ICI管理相结合.
结论:
- 免疫细胞死亡 (ICD) 诱导和免疫检查点抑制剂 (ICI) 的组合代表了抗癌疗法的前沿.
- 进一步的研究和临床试验对于优化这些组合策略以改善患者结果至关重要.
- 这种方法有可能增强持久的反应,并扩大对更广泛的癌症的治疗选择.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cell-mediated Immune Responses
68.3K
Overview
68.3K
Vaccinations
44.5K
Overview
44.5K
Immunodeficiency Diseases
941
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
941
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Cytotoxic T Cells-mediated Immune Response
921
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921

